The effects of aminophylline given intravenously on the pulmonary circulation and left ventricular performance were studied during combined right and transseptal left heart catheterization in 32 patients with mitral and aortic valvular disease. We recorded complete data on the changes of the pulmonary vascular distending pressure (PD) and the pulmonary blood volume (PBV) before and during aminophylline infusion in 28 patients. In 19 patients a fall in the PD was associated with a rise in the PBV. In eight patients a decline in the PD was accompanied by a fall (five patients) or no change (three patients) in the PBV. In a single case, both PD and the PBV rose. In the majority of cases, observation of decrease in PD and a discordant rise in PBV is new evidence suggestive of a direct active vasodilating effect of aminophylline on the pulmonary vasculature.
SUMMARY
The effects of aminophylline given intravenously on the pulmonary circulation and left ventricular performance were studied during combined right and transseptal left heart catheterization in 32 patients with mitral and aortic valvular disease. We recorded complete data on the changes of the pulmonary vascular distending pressure (PD) and the pulmonary blood volume (PBV) before and during aminophylline infusion in 28 patients. In 19 patients a fall in the PD was associated with a rise in the PBV. In eight patients a decline in the PD was accompanied by a fall (five patients) or no change (three patients) in the PBV. In a single case, both PD and the PBV rose. In the majority of cases, observation of decrease in PD and a discordant rise in PBV is new evidence suggestive of a direct active vasodilating effect of aminophylline on the pulmonary vasculature.
Although the cardiac index was unaffected, a positive inotropic effect on the myocardium was documented by a decrease in left ventricular end-diastolic pressure accompanied by an increase in the maximum rate of ventricular pressure rise (LV dp/dt). These findings contrast with those in certain patients with heart failure of nonvalvular origin in whom increases in cardiac index are usually prominent. The salutory effect of aminophylline in acute pulmonary edema is thought to be due to synergistic effects on the systemic circulation, pulmonary circulation, and left ventricular function, all of which tend to produce a fall in PD.
Additional Indexing Words: Pulmonary The positive inotropic effect of aminophylline on the myocardium in animals and in certain patients with nonvalvular heart disease has been well documented.Y'0 In patients with rheumatic heart disease, however, aminophylline frequently does not produce a rise in cardiac output,7' 11, 12 and the nature of the action of the drug on the ventricles has not been evaluated in this group of patients.
The purpose of this study, conducted on a group of patients with valvular heart disease, is (1) to describe further the effect of aminophylline on the human pulmonary circulation with specific reference to its possible pulmonary vascular dilating action, and (2) to assess the effects of the drug on left ventricular performance in these patients.
Methods
The effects of aminophylline given intravenously were studied during combined right and transseptal left heart catheterization in 32 patients with valvular heart disease. These patients were divided into two groups on the basis of valve involvement. The An estimate of left ventricular performance was made by assessment of chanpes in left ventricular end-diastolic pressure (LVEDP), stroke work, and the maximum rate of rise of left ventricular systolic pressure (LV dp/dt). Measurement of LV dp/dt has been considered useful in estimating changes in myocardial contractility in man.17 In our laboratory, LV dp/dt is measured by means of an RC differentiating circuit connected to the output of the recording amplifier. This technique is used to obtain an estimate of relative changes in the maximum rate of systolic pressure rise. Direct calibration of LV dp/dt in mm Hg/ sec is not attempted because of nonlinear catheter-gauge frequency response characteristics. 18 To aid in the distinction between a direct active vasomotor action of the drug as opposed to indirect passively induced alterations in the pulmonary vascular bed, the relationship between changes in the PBV and the mean pulmonary vascular distending pressure (PD) is used.13 15 (PD) is calculated as follows:
where PAm and LAm are mean pulmonary artery and left atrial pressures, respectively. According to this hypothesis, a concordant rise in both PD and PBV suggests passive dilation of the pulmonary vasculature; a fall in PD and rise in PBV are consistent with active pulmonary vascular dilation.
During the control period, measurements of intravascular pressures, cardiac index, and the PBV were made with the catheters positioned in both pulmonary artery trunk and left atrium. The left heart catheter was then advanced into the left ventricle (LV). Control values of LV pressure at high and low gain levels were recorded, along with control estimate of LV dp/dt. Aminophylline was then infused intravenously over a 10-to 12-minute interval in doses of 250, 500, or 750 mg, while pressures, LV dp/dt, and the electrocardiogram were monitored continuously. Immediately after completion of the infusion, the left heart catheter was withdrawn from the LV to its original position within the LA and all the original measurements were repeated.
Results
The hemodynamic responses to aminophylline infusion in groups I and II are shown in tables I and 2, respectively. Change in PD (APD) after aminophylline on the horizontal axis plotted against change in PBV (APBV) on the vertical axis in 16 7 A dp LV dt + Figure 3 Efects of aminophylline on LV dpldt in 16 patients. Changes in LV dp/dt after aminophylline are plotted as percentages of the control values.
panied by a slight decrease in stroke index, stroke work index, and systemic arterial pressure, was produced. As in group I, a highly significant decrease in PAm, LAm and PD occurred. Thirteen of these 14 patients showed a decrease in PD, while in the remaining patient no change occurred.
A significant rise in PBV, averaging 31 ml/m2, was noted ( fig. 2) , and in this group the PVR declined moderately.
Ventricular Performance
In the 21 patients in both groups I and II in whom LVEDP was measured, a decrease was noted in 12 patients, in six it was unchanged, and in three it rose slightly. In group I, the numbers were too small for analysis, while in group II the decrease was statistically significant. Decreases were often larger in subjects with initially rather high LVEDP.
LV dp/dt gradually rose in the majority of patients during the infusion ( fig. 3 ). The increase in LV dp/dt did not correlate with changes in systemic arterial diastolic or mean pressure or heart rate. In addition, the magnitude of decrease in LVEDP bore no apparent relationship to the observed rise in LV dp/dt. Thus, several patients showing no change or even a slight rise in LVEDP had a prominent increase in LV dp/dt. Many studies concerning the action of aminophylline on the pulmonary circulation have been conducted on man as well as in animals, but the exact nature of its direct effects, if any, on the blood vessels of the pulmonary vasculature has proved difficult to characterize with certainty. Moreover, the pharmacological effects of this drug on the systemic circulation apparently differ depending on the underlying pathological state. In patients with congestive cardiac failure, resulting from either hypertensive or coronary heart disease, a fall in ventricular diastolic pressure as well as increased cardiac output has been a consistent finding following administration of aminophylline.7-10 However, in subjects with pulmonary heart disease'9 and in those with valvular heart disease,7' 11, 12 similar doses of the drug do not result in a consistent change in cardiac output. In this respect, the results in this study are similar to observations made by others in the past. In contrast to the lack of change in output, aminophylline produced a distinctly positive inotropic effect on the left ventricular myocardium of these patients. This action was manifested by a consistent increase in LV dp/dt as well as a general tendency for LVEDP to decrease. The rise in dp/dt in these subjects probably reflects development of higher peak myocardial tension during early systole and is similar to observations in animals using strain gauges attached directly to the heart.6 The rise in LV dp/dt in our patients cannot be attributed to either acceleration of the heart rate or rise in systemic arterial diastolic pressure, both of which may independently affect dp/dt.
In the patients with aortic valve disease, the slight tendency for fall in effective stroke index does not necessarily imply that the contractile state of the ventricle has diminished. More likely, this small change, in association with a rise in LV dp/dt and frequently a fall in LVEDP, suggests a new ventricular function point located on the classic ventricular function diagram almost horizontally to the left of the old one. This The dissociation of the effects of aminophylline on myocardial contractility and cardiac output has not been satisfactorily explained. Simultaneous peripheral vasodilation and reduction in venous return may play a role.20 Sequential measurements of central venous pressure were not recorded in this investigation, and thus we cannot elucidate this point further. At any rate, the present study indicates that qualitative differences in the myocardial effect are not a factor. Possibly the independent influence of obstructive or regurgitant lesions rather than myocardial dysfunction is the major determinant limiting cardiac output in these patients.
Aminophylline consistently lowers pressures in the pulmonary circulation. This effect, often accompanied by a fall in PVR, has been considered evidence suggestive of pulmonary vasodilation. Uncertainty 
